Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Debt / NOTE 4/0
-
Market price (% of par)
-
91.0%
-
Total 13F principal
-
$505,388,900
-
Principal change
-
+$505,386,400
-
Total reported market value
-
$438,363,173
-
Number of holders
-
33
-
Value change
-
+$438,355,273
-
Number of buys
-
32
Institutional Holders of IONIS PHARMACEUTICALS INC - NOTE 4/0 as of Q2 2022
As of 30 Jun 2022,
IONIS PHARMACEUTICALS INC - NOTE 4/0 was held by
33 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$505,388,900
in principal (par value) of the bond.
The largest 10 bondholders included
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), WOLVERINE ASSET MANAGEMENT LLC, TENOR CAPITAL MANAGEMENT Co., L.P., ADVENT CAPITAL MANAGEMENT /DE/, BlackRock Inc., MACKAY SHIELDS LLC, WHITEBOX ADVISORS LLC, Magnetar Financial LLC, CAPSTONE INVESTMENT ADVISORS, LLC, and AMERIPRISE FINANCIAL INC.
This page lists
34
institutional bondholders reporting positions
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.